Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miho Ushijima

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Science|February 4, 2022
An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancerMiho Ushijima, Masaki Shiota, Takashi Matsumoto, et al.
Lower Urinary Tract Symptoms|October 22, 2020
New mouse model of underactive bladder developed by placement of a metal ring around the bladder neckKareman Eljamal, Shunichi Kajioka, Tomoko Maki, et al.
The Journal of Biological Chemistry|December 29, 2016
DOCK8 Protein Regulates Macrophage Migration through Cdc42 Protein Activation and LRAP35a Protein InteractionAkira Shiraishi, Takehito Uruno, Fumiyuki Sanematsu, et al.
Frontiers in Immunology|March 6, 2018
The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody ProductionMiho Ushijima, Takehito Uruno, Akihiko Nishikimi, et al.
Cancer Science|July 13, 2026
Proteomic Analysis Reveals AMPKα-Mediated Antiandrogen Resistance via Ferroptosis Suppression in Prostate CancerMasaki Shiota, Tokiyoshi Tanegashima, Takahiko Hajime, et al.
The Prostate|May 12, 2019
Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapyMasaki Shiota, Miho Ushijima, Kenjiro Imada, et al.
Free Radical Biology & Medicine|May 18, 2024
Oxidative stress in peroxisomes induced by androgen receptor inhibition through peroxisome proliferator-activated receptor promotes enzalutamide resistance in prostate cancerMasaki Shiota, Miho Ushijima, Shigehiro Tsukahara, et al.
American Journal of Translational Research|July 14, 2020
The role of adipocytokines and their receptors in bladder cancer: expression of adiponectin or leptin is an independent prognosticatorEiji Kashiwagi, Tatsuro Abe, Fumio Kinoshita, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2019
The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese menMasaki Shiota, Naohiro Fujimoto, Shigehiro Tsukahara, et al.
The Prostate|June 3, 2020
High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancerMomoe Itsumi, Masaki Shiota, Yohei Sekino, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Science|February 4, 2022
An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancerMiho Ushijima, Masaki Shiota, Takashi Matsumoto, et al.
Lower Urinary Tract Symptoms|October 22, 2020
New mouse model of underactive bladder developed by placement of a metal ring around the bladder neckKareman Eljamal, Shunichi Kajioka, Tomoko Maki, et al.
The Journal of Biological Chemistry|December 29, 2016
DOCK8 Protein Regulates Macrophage Migration through Cdc42 Protein Activation and LRAP35a Protein InteractionAkira Shiraishi, Takehito Uruno, Fumiyuki Sanematsu, et al.
Frontiers in Immunology|March 6, 2018
The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody ProductionMiho Ushijima, Takehito Uruno, Akihiko Nishikimi, et al.
Cancer Science|July 13, 2026
Proteomic Analysis Reveals AMPKα-Mediated Antiandrogen Resistance via Ferroptosis Suppression in Prostate CancerMasaki Shiota, Tokiyoshi Tanegashima, Takahiko Hajime, et al.
The Prostate|May 12, 2019
Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapyMasaki Shiota, Miho Ushijima, Kenjiro Imada, et al.
Free Radical Biology & Medicine|May 18, 2024
Oxidative stress in peroxisomes induced by androgen receptor inhibition through peroxisome proliferator-activated receptor promotes enzalutamide resistance in prostate cancerMasaki Shiota, Miho Ushijima, Shigehiro Tsukahara, et al.
American Journal of Translational Research|July 14, 2020
The role of adipocytokines and their receptors in bladder cancer: expression of adiponectin or leptin is an independent prognosticatorEiji Kashiwagi, Tatsuro Abe, Fumio Kinoshita, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2019
The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese menMasaki Shiota, Naohiro Fujimoto, Shigehiro Tsukahara, et al.
The Prostate|June 3, 2020
High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancerMomoe Itsumi, Masaki Shiota, Yohei Sekino, et al.
Pageof 3